DOI resolved by resea
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor on resea.org. DOI 10.1016/j.cell.2020.02.052. Markus Hoffmann, Hannah Kleine‐Weber…
Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S. Schiergens, Georg Herrler
https://resea.org/10.1016/j.cell.2020.02.052